Hemangiomas: An overview

Clinical Pediatrics

Volumn 46, Issue 3, 2007, Pages 206-221

  Sundine, Michael J ^a   Wirth, Garrett A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALPHA SMOOTH MUSCLE ACTIN; ALPHA2A INTERFERON; ALPHA2B INTERFERON; BASIC FIBROBLAST GROWTH FACTOR; BETAMETHASONE ACETATE; BLEOMYCIN; CD31 ANTIGEN; CORTICOSTEROID; CYCLINE; CYCLOPHOSPHAMIDE; GELATINASE A; INTERLEUKIN 8; POTASSIUM DERIVATIVE; POTASSIUM TITANYLPHOSPHATE; PREDNISOLONE; PREDNISONE; THROMBOCYTE FACTOR 4; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA; TRIAMCINOLONE ACETONIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UROKINASE; VASCULOTROPIN; VINCRISTINE; VON WILLEBRAND FACTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANGIOGENESIS; AORTA COARCTATION; ARTIFICIAL EMBOLISM; AUTOSOMAL DOMINANT INHERITANCE; BLEEDING; BRAIN MALFORMATION; CAPILLARY HEMANGIOMA; CAVERNOUS HEMANGIOMA; CHORION VILLUS SAMPLING; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONGENITAL BLOOD VESSEL MALFORMATION; CONGENITAL HEART MALFORMATION; CONGESTIVE HEART FAILURE; CORTICOSTEROID THERAPY; CRYOSURGERY; DANDY WALKER SYNDROME; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EAR DISEASE; EYE MALFORMATION; GENE EXPRESSION; HEAD AND NECK TUMOR; HEMANGIOMA; HISTOLOGY; HUMAN; INCIDENCE; INFECTION; KAPOSI SARCOMA; KAPOSIFORM HEMANGIOENDOTHELIOMA; KASABACH MERRITT SYNDROME; MALFORMATION SYNDROME; MEDICAL DECISION MAKING; MOLECULAR BIOLOGY; NEODYMIUM LASER; NUCLEAR MAGNETIC RESONANCE IMAGING; PHACE SYNDROME; PROTEIN FUNCTION; RADIODIAGNOSIS; REVIEW; SEX DIFFERENCE; SKELETON MALFORMATION; SOCIAL PSYCHOLOGY; TUMOR CLASSIFICATION; TUMOR GROWTH; ULCER;

BIOLOGICAL MARKERS; GLUCOCORTICOIDS; HEMANGIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; INTERFERON-ALPHA; LASERS;

EID: 34047240613     PISSN: 00099228     EISSN: None     Source Type: Journal    
DOI: 10.1177/0009922806290455     Document Type: Review

References (128)

1. Mulliken JB Vascular birthmarks in folklore, history, art, and literature. In Mulliken JB, Young AE, eds. Vascular Birthmarks: Hemangiomas and Malformations. Philadelphia, Pa: WB Saunders Company ; 1988: 3-23.
2. Drolet BA, Esterly NB, Frieden IJ Hemangiomas in children. N Engl J Med. 1999 ; 341: 173-181.
3. Robertson RL, Robson CD, Barnes PD, et al. Head and neck vascular anomalies of childhood. Neuroimaging Clin North Am. 1999 ; 9: 115-132.
4. Pratt AG Birthmarks in infants. Arch Dermatol. 1953 ; 67: 302-305.
5. Jacobs AH, Walton RG The incidence of birthmarks in the neonate. Pediatrics. 1976 ; 58: 218-222.
6. Bivings L. Spontaneous regression of angiomas in children. J Pediatr. 1954 ; 45: 643-647.
7. Jacobs AH Strawberry hemangioma: the natural history of the untreated lesion. Calif Med. 1957 ; 86: 8-10.
8. Amir J., Metzker A., Krikler R., et al. Strawberry hemangioma in preterm infants. Pediatr Dermatol. 1986 ; 3: 331-332.
9. Holmdahl K. Cutaneous hemangiomas in premature and mature infants. Acta Paediatrica. 1955 ; 44: 370-379.
10. Osburn K., Schosser RH, Everett MA Congenital pigmented and vascular lesions in newborn infants. J Am Acad Dermatol. 1987 ; 16: 788-791.
11. Bowers RE, Graham EA, Tomlinson KM The natural history of the strawberry nevus. Arch Dermatol. 1969 ; 82: 667-680.
12. Margileth AM, Museles M. Cutaneous hemangiomas in children. JAMA. 1965 ; 194: 523-526.
13. Enjolras O., Mulliken JB The current management of vascular birthmarks. Pediatr Dermatol. 1993 ; 10: 311-333.
14. Finn MC, Glowacki J., Mulliken JB Congenital vascular lesions: clinical application of a new classification. J Pediatr Surg. 1983 ; 18: 894-900.
15. Burton BK, Schulz CJ, Angle F., et al. An increased incidence of haemangiomas in infants born following chorionic villus sampling (CVS). Prenat Diagn. 1995 ; 15: 209-214.
16. Mueller BU, Mulliken JB The infant with a vascular tumor. Semin Perinatol. 1999 ; 20: 332-340.
17. Blei F., Walter J., Orlow SJ, et al. Familial segregation of hemangiomas and vascular malformations as an autosomal dominant trait. Arch Dermatol. 1998 ; 134: 718-722.
18. Cheung DS, Warman ML, Mulliken JB Hemangioma in twins. Ann Plast Surg. 1997 ; 38: 269-274.
19. Pack GT, Miller TR Hemangiomas: classification, diagnosis, and treatment. Angiology. 1950 ; 1: 405-426.
20. Malan, E. Vascular Malformations (Angiodysplasias). Milan, Italy: Carlo Erba Foundation ; 1974: 38-41.
21. Folkman J., Klagsbrun M. Angiogenic factors. Science. 1987 ; 235: 442-447.
22. Mulliken JB, Young AE Diagnosis and natural history of hemangiomas. In: Mulliken JB, Young AE, eds. Vascular Birthmarks: Hemangiomas and Malformations. Philadelphia, Pa: WB Saunders Company ; 1988: 41-46.
23. Folkman J. Clinical applications of research on angiogenesis. N Engl J Med. 1995 ; 333: 1757-1763.
24. Powell J. Update on hemangiomas and vascular malformations. Curr Opin Pediatr. 1999 ; 1 1: 457-463.
25. Sasaki GH, Pang CY, Wittliff JL Pathogenesis and treatment of infant skin strawberry hemangiomas: clinical and in vitro studies of hormonal effects. Plast Reconstr Surg. 1984 ; 73: 359-368.
26. Xiao X., Hong L., Sheng M. Promoting effect of estrogen on the proliferation of hemangioma vascular endothelial cells in vitro. J Pediatr Surg. 1999 ; 34: 1603-1605.
27. Mulliken JB Cutaneous vascular anomalies. In: McCarthy JG, ed. Plastic Surgery. Philadelphia, Pa: WB Saunders Company ; 1990: 3191-3274.
28. Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg. 1982 ; 69: 412-420.
29. Finn MC, Glowacki J., Mulliken JB Congenital vascular lesions: clinical application of a new classification. J Pediatr Surg. 1983 ; 18: 894-900.
30. Enjolras O. Classification and management of the various superficial vascular anomalies: hemangiomas and vascular malformations. J Dermatol. 1997 ; 24: 701-710.
31. Burrows PE, Laor T., Paltiel H., Robertson RL Diagnostic imaging in the evaluation of vascular birthmarks. Derm Clin. 1998 ; 16: 455-488.
32. Kenkel JM, Burns AJ Vascular anomalies, lasers, and lymphedema (overview). Select Read Plast Surg. 1995 ; 8: 1-47.
33. Payne MM, Moyer F., Marcks KM, Trevaskis AE The precursor to the hemangioma. Plast Reconstr Surg. 1966 ; 38: 64-67.
34. Hidano A., Nakajima S. Earliest features of the strawberry mark in the newborn. Br J Derm. 1972 ; 87: 138-144.
35. Pasyk KA, Cherry GW, Grabb WC, Sasaki GH Quantitative evaluation of mast cells in cellularly dynamic and adynamic vascular malformations. Plast Reconstr Surg. 1984 ; 73: 69-77.
36. Lister WA The natural history of strawberry nevi. Lancet. 1938 ; 1: 1429-1434.
37. Simpson JR Natural history of cavernous haemangiomata. Lancet. 1959 ; 2: 1057-1059.
38. Boon LM, Enjolras O., Mulliken JB Congenital hemangioma: evidence of accelerated involution. J Pediatr. 1996 ; 128: 329-335.
39. Mulliken JB Pathogenesis of hemangiomas. In: Mulliken JB, Young AE, eds. Vascular Birthmarks: Hemangiomas and Malformations. Philadelphia, Pa: WB Saunders Company ; 1988: 63-76.
40. Glowacki J., Mulliken JB Mast cells in hemangiomas and vascular malformations. Pediatrics. 1981 ; 70: 48-51.
41. Enjolras O., Mulliken JB Vascular tumors and vascular malformations (new issues). Adv Dermatol. 1998 ; 13: 375-423.
42. Enjolras O. Vascular tumors and vascular malformations: are we at the dawn of a better knowledge? Pediatr Dermatol. 1999 ; 16: 238-241.
43. Blei F. New clinical observations in hemangiomas. Sem Cut Med Surg. 1999 ; 18: 187-194.
44. Vikkula M., Boon LM, Mulliken JB, et al. Molecular basis of vascular anomalies. Trends Cardiovasc Med. 1998 ; 8: 281-292.
45. Takahashi K., Mulliken JB, Kozakewich Hpw, et al. Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J Clin Invest. 1994 ; 93: 2357-2364.
46. Chang J., Most D., Bresnick S., et al. Proliferative hemangiomas: analysis of cytokine gene expression and angiogenesis. Plast Reconstr Surg. 1999 ; 103: 1-9.
47. Kraling BM, Razon MJ, Boon LM, et al. E-selectin is present in proliferating endothelial cells in human hemangiomas. Am J Path. 1996 ; 148: 1181-1191.
48. Isik FF, Rand RP, Gruss JS, Benjamin D., et al. Monocyte chemoattractant protein-1 mRNA expression in hemangiomas and vascular malformations. J Surg Res. 1996 ; 61: 71-76.
49. Jang Y-C., Arumugam S., Ferguson M., et al. Changes in matrix composition during the growth and regression of human hemangiomas. J Surg Res. 1998 ; 80: 9-15.
50. Razon MJ, Kraling BM, Mulliken JB, et al. Increased apoptosis coincides with onset of involution in infantile hemangioma. Microcirculation. 1998 ; 5: 189-195.
51. Mancini AJ, Smoller BR Proliferation and apoptosis within juvenile capillary hemangiomas. Am J Dermatopath. 1996 ; 18: 505-514.
52. Martinez-Perez D., Fein NA, Boon LM, et al. Not all hemangiomas look like strawberries: uncommon presentations of the most common tumor of infancy. Pediatr Dermatol. 1995 ; 12: 1-6.
53. Burrows PE, Mulliken JB, Fellows KE, et al. Childhood hemangiomas and vascular malformations: angiographic differentiation. AJR Am J Roentgenol. 1983 ; 141: 483-488.
54. Yang WT, Ahuja A., Metreweli C. Sonographic features of head and neck hemangiomas and vascular malformations: review of 23 patients. J Ultrasound Med. 1997 ; 16: 39-44.
55. Dubois J., Garel L., Grignon A., et al. Imaging of hemangiomas and vascular malformations in children. Acad Radiol. 1998 ; 5: 390-400.
56. Dubois J., Patriquin HB, Garel L., et al. Soft-tissue hemangiomas in infants and children: diagnosis using doppler sonography. AJR Am J Roentgenol. 1998 ; 171: 247-252.
57. Robertson RL, Robson CD, Barnes PD, et al. Head and neck vascular anomalies of childhood. Neuroimaging Clin North Am. 1999 ; 9: 115-132.
58. Meyer JS, Hoffer FA, Barnes PD, et al. Biological classification of soft-tissue vascular anomalies: MR correlation. AJR Am J Roentgenol. 1991 ; 157: 559-564.
59. Enjolras O., Riche MC, Merland JJ, et al. Management of alarming hemangiomas in infancy: a review of 25 cases. Pediatrics. 1990 ; 85: 491-498.
60. Management of hemangiomas. Pediatr Dermatol. 1997 ; 14: 57-83.
61. Garden JM, Bakus AD Laser treatment of port-wine stains and hemangiomas. Dermatol Clin. 1997 ; 15: 373-383.
62. Haik GR, Jakobiec FA, Ellsworth RM, et al. Capillary hemangioma of the lids and orbit. An analysis of the clinical features and therapeutic results in 101 cases. Ophthalmology. 1979 ; 86: 760-789.
63. Stigmar G., Crawford JS, Ward CM, et al. Ophthalmic sequelae of infantile hemangiomas of the eyelids and orbit. Am J Ophthalmol. 1978 ; 85: 806-813.
64. Goldberg NS, Rosanova MA Periorbital hemangiomas. Dermatol Clin. 1992 ; 10: 653-661.
65. Orlow SJ, Isakoff MS, Blei F. Increased risk of symptomatic hemangiomas of the airway in association with cutaneous hemangiomas in a "beard" distribution. J Pediatr. 1997 ; 131: 643-646.
66. Brown TJ, Friedman J., Levy ML The diagnosis and treatment of common birthmarks. Clin Plast Surg. 1998 ; 25: 509-525.
67. Van Den Abbeele T., Triglia JM, Lescanne E., et al. Surgical removal of subglottic hemangiomas in children. Laryngoscope. 1999 ; 109: 1281-1286.
68. Vin-Christian K., McCalmont TH, Frieden IJ Kaposiform hemangioendothelioma-an aggressive, locally invasive vascular tumor that can mimic hemangioma of infancy. Arch Dermatol. 1997 ; 133: 1573-1578.
69. Enjolras O., Wassef M., Mazoyer E., et al. Infants with Kasabach-Merritt syndrome do no have "true" hemangiomas. J Pediatr. 1997 ; 130: 631-640.
70. Sarkar M., Mulliken JB, Kozakewich Hpw, et al. Thrombocytopenic coagulopathy (Kasabach-Merritt phenomenon) is associated with Kaposiform hemangioendothelioma and not with common infantile hemangioma. Plast Reconstr Surg. 1997 ; 100: 1377-1386.
71. Reese V., Frieden IJ, Paller AS, et al. Association of facial hemangiomas with Dandy-Walker and other posterior fossa malformations. J Pediatr. 1993 ; 122: 379-383.
72. Frieden IJ, Reese V., Cohen D. PHACE syndrome-the association of posterior fossa brain malformations, hemangiomas, arterial anomalies, coarctation of the aorta and cardiac defects, and eye abnormalities. Arch Dermatol. 1996 ; 132: 307-311.
73. Albright AL, Gartner JC, Wiener ES Lumbar cutaneous hemangiomas as indicators of tethered spinal cords. Pediatrics. 1988 ; 83: 977-980.
74. Goldberg NS, Hebert AA, Esterly NB Sacral hemangiomas and multiple congenital abnormalities. Arch Dermatol. 1986 ; 22: 684-687.
75. Ezekowitz Rab. The relationship between facial and airway hemangiomas: does seeing red bode ill? J Pediatr. 1997 ; 131: 514-515.
76. Pfeiffer N. Guidelines for treating different stages of hemangioma. J Clin Laser Med Surg. 1994 ; 12: 239-240.
77. Frieden IJ, Eichenfield LF, Esterly NB, et al. Guidelines for care of hemangiomas of infancy. J Am Acad Dermatol. 1997 ; 37: 631-637.
78. Frieden IJ Which hemangiomas to treat-and how? Arch Dermatol. 1997 ; 133: 1593-1595.
79. Achauer BM, Chang C-J., Vander Kam VM. Management of hemangioma of infancy: review of 245 patients. Plast Reconstr Surg. 1997 ; 99: 1301-1308.
80. Jackson IT, Carreno R., Potparic Z., et al. Hemangiomas, vascular malformations, and lymphovenous malformations: classification and methods of treatment. Plast Reconstr Surg. 1993 ; 91: 1216-1230.
81. Forte V., Triglia JM, Zalzal G. Hemangioma. Head Neck. 1998 ; 20: 69-72.
82. Mulliken JB A plea for a biologic approach to hemangiomas of infancy. Arch Dermatol. 1991 ; 127: 243-244.
83. Tanner JL, Dechert MP, Frieden IJ Growing up with a facial hemangioma: parent and child coping with adaptation. Pediatrics. 1998 ; 101: 466-452.
84. Zarem HA, Edgerton MT Induced resolution of cavernous hemangiomas following prednisolone therapy. Plast Reconstr Surg. 1967 ; 39: 76-83.
85. Frost, NC, Esterly NB Successful treatment of juvenile hemangiomas with prednisone. J Pediatr. 1968 ; 72: 351-357.
86. Edgerton MT The treatment of hemangiomas: with special reference to the role of steroid therapy. Ann Surg. 1976 ; 183: 517-532.
87. Kushner BJ Intralesional corticosteroid injection for infantile adnexal hemangioma. Am J Ophthalmol. 1982 ; 93: 496-506.
88. Kushner BJ The treatment of periorbital infantile hemangioma with intralesional corticosteroid. Plast Reconstr Surg. 1985 ; 76: 517-524.
89. Sloan GM, Reinisch JF, Nichter LS, et al. Intralesional corticosteroid therapy for infantile hemangiomas. Plast Reconstr Surg. 1989 ; 83: 459-466.
90. Gangopadhyay AN, Sinha CK, Gopal SC, et al. Role of steroid in childhood hemangioma: a 10 years review. Int Surg. 1997 ; 82: 49-51.
91. Boon LM, MacDonald DM, Mulliken JB Complications of systemic corticosteroid therapy for porblematic hemangioma. Plast Reconstr Surg. 1999 ; 104: 1616-1623.
92. Kushner BJ Hemangiomas in children. N Engl J Med. 1999 ; 341: 2018.
93. Ezekowitz Rab, Mulliken JB, Folkman J. Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med. 1992 ; 326: 1456-1463.
94. White CW, Sondheimer HM, Crouch EC, et al. Treatment of pulmonary hemangiomatosis with recombinant interferon alfa-2a. N Engl J Med. 1989 ; 320: 1197-1200.
95. Bauman NM, Burke DK, Smith Rjh. Treatment of massive or life-threatening hemangiomas with recombinant 2a-interferon. Otolaryngol Head Neck Surg. 1997 ; 117: 99-110.
96. Hastings MM, Milot J., Barsoum-Homsy M., et al. Recombinant interferon alfa-2b in the treatment of vision-threatening capillary hemangiomas in childhood. JAAPOS. 1997 ; 1: 226-230.
97. Egbert JE, Nelson SC Neurologic toxicity associated with interferon alfa treatment of capillary hemangioma. JAAPOS. 1997 ; 1: 190.
98. Castello MA, Ragni G., Antini A., et al. Successful management with interferon alpha-2a after prednisone therapy failure in an infant with a giant cavernous hemangioma. Med Pediatr Oncol. 1997 ; 28: 213-215.
99. Tamayo L., Ortiz DM, Orozco-Covarrubias L., et al. Therapeutic efficacy of interferon alfa-2b in infants with life-threatening giant hemangiomas. Arch Dermatol. 1997 ; 133: 1567-1571.
100. Barlow CF, Reiebe CJ, Mulliken JB, et al. Spastic diplegia as a complication of interferon alfa-2a treatment of hemangiomas of infancy. J Pediatr. 1998 ; 132: 527-530.
101. Tryfonas GI, Tsikopoulos G., Liasidou E., et al. Conservative treatment of hemangiomas of infancy and childhood with interferon-alpha 2a. Pediatr Surg Int. 1998 ; 13: 590-593.
102. Leaute-Labreze C., Taieb A. Caution with regard to the efficacy of interferon alfa-2b in the treatment of giant hemangiomas. Arch Dermatol. 1998 ; 134: 1297-1298.
103. Enjolras O. Neurotoxicity of interferon alfa in children treated for hemangiomas. J Am Acad Dermatol. 1998 ; 36: 1037-1038.
104. Greinwald JH, Burke DK, Bonthius DJ, et al. An update on the treatment of hemangiomas in children with interferon alfa-2a. Arch Otolaryngol Head Neck Surg. 1999 ; 125: 21-27.
105. Chang E., Boyd A., Nelson CC, et al. Successful treatment of infant hemangiomas with interferon -2b. J Pediatr Hematol Oncol. 1997 ; 19: 237-244.
106. Rosenfeld H., Sherman R. Treatment of cutaneous and deep vascular lesions with the Nd:YAG laser. Lasers Surg Med. 1986 ; 6: 20-23.
107. Apfelberg DB, Greene RA, Maser R., et al. Results of argon laser exposure of capillary hemangiomas of infancy-preliminary report. Plast Reconstr Surg. 1981 ; 67: 188-193.
108. Hobby LW Further evaluation of the potential of the argon laser in the treatment of strawberry hemangiomas. Plast Reconstr Surg. 1983 ; 71: 481-485.
109. Achauer BM, Vander Kam VM. Capillary hemangioma (strawberry mark) of infancy: comparison of argon and Nd:YAG laser treatment. Plast Reconstr Surg. 1989 ; 84: 60-69.
110. Apfelberg DB, Smith T., Lash H. Preliminary report on use of the neodymium-YAG laser in plastic surgery. Lasers Surg Med. 1987 ; 7: 189-198.
111. Preeyanont P., Nimsakul N. The Nd:YAG laser treatment of hemangioma. J Clin Laser Med Surg. 1994 ; 12: 225-229.
112. Anderson RR, Parrish JA Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science. 1983 ; 220: 524-527.
113. Garden JM, Bakus AD Laser treatment of port-wine stains and hemangiomas. Dermatol Clin. 1997 ; 15: 373-383.
114. Garden JM, Bakus AD, Paller AS Treatment of cutaneous hemangiomas by the flashlamp-pumped pulsed dye laser: prospective analysis. J Pediatr. 1992 ; 120: 555-560.
115. Sherwood KA, Tan OT The treatment of a capillary hemangioma with the flashlamp pumped-dye laser. J Am Acad Dermatol. 1990 ; 22: 136-137.
116. Ashinoff R., Geronemus RG Capillary hemangiomas and treatment with the flash lamp-pulsed dye laser. Arch Dermatol. 1991 ; 127: 202-205.
117. Scheepers JH, Quaba AA Does the pulsed tunable dye laser have a role in the management of infantile hemangiomas? Observations based on 3 years experience. Plast Reconstr Surg. 1995 ; 95: 305-312.
118. Tong Mcf, Van Hasselt CA The 578-nm copper vapor laser in the treatment of cavernous hemangiomas in the oral cavity. J Clin Laser Med Surg. 1994 ; 12: 109-110.
119. Gregory RO Treatment of cavernous hemangiomas with intralesional ablation with YAG laser. Lasers Surg Med. 1991 ; 11 (suppl 3). 66.
120. Apfelberg DB Intralesional laser photocoagulation-steroids as an adjunct to surgery for massive hemangiomas and vascular malformations. Ann Plast Surg. 1995 ; 35: 144-148.
121. Achauer BM, Celikoz B., Vander Kam VM. Intralesional bare fiber laser treatment of hemangioma of infancy. Plast Reconstr Surg. 1998 ; 101: 1212-1217.
122. Achauer BM, Chang C-J., Vander Kam VM. Intralesional photocoagulation of periorbital hemangiomas. Plast Reconstr Surg. 1999 ; 103: 11-16.
123. Chang C-J., Anvari B., Nelson JS Cryogen spray cooling for spatially selective photocoagulation of hemangiomas: a new methodology with preliminary clinical reports. Plast Reconstr Surg. 1998 ; 102: 459-463.
124. Cremer H. Cryosurgery for hemangiomas. Pediatr Dermatol. 1998 ; 15: 410-411.
125. Hurvitz CH, Alkalay AL, Sloninsky L., et al. Cyclophosphamide therapy in life-threatening vascular tumors. J Pediatr. 1986 ; 109: 360-363.
126. Kullendorf CM Efficacy of bleomycin treatment for symptomatic hemangiomas in children. Pediatr Surg Int. 1997 ; 12: 526-528.
127. Perez J., Pardo J., Gomez C. Vincristine-an effective treatment of corticoid-resistant life-threatening infantile hemangiomas. Acta Oncol. 2002 ; 41: 197-199.
128. O'Reilly MS, Boehm T., Shing Y., et al. Endostatin: an endogenous inhibitior of angiogenesis and tumor growth. Cell. 1997 ; 88: 277-285.